MedPath

clobazam

These highlights do not include all the information needed to use CLOBAZAM TABLETS safely and effectively. See full prescribing information for CLOBAZAM TABLETS. CLOBAZAM tablets, for oral use, CIV Initial U.S. Approval: 2011

Approved
Approval ID

dd6a7bde-62c5-43e2-81f8-1f7dd63757b3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 28, 2023

Manufacturers
FDA

Breckenridge Pharmaceutical, Inc.

DUNS: 150554335

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CLOBAZAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51991-900
Application NumberANDA209308
Product Classification
M
Marketing Category
C73584
G
Generic Name
CLOBAZAM
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 1, 2023
FDA Product Classification

INGREDIENTS (7)

CLOBAZAMActive
Quantity: 10 mg in 1 1
Code: 2MRO291B4U
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

CLOBAZAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51991-958
Application NumberANDA209308
Product Classification
M
Marketing Category
C73584
G
Generic Name
CLOBAZAM
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 1, 2023
FDA Product Classification

INGREDIENTS (7)

CLOBAZAMActive
Quantity: 5 mg in 1 1
Code: 2MRO291B4U
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

CLOBAZAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51991-901
Application NumberANDA209308
Product Classification
M
Marketing Category
C73584
G
Generic Name
CLOBAZAM
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 1, 2023
FDA Product Classification

INGREDIENTS (7)

CLOBAZAMActive
Quantity: 20 mg in 1 1
Code: 2MRO291B4U
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

clobazam - FDA Drug Approval Details